SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q2 2020 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS)
Q2 2020 Results Conference Call
August 06, 2020 08:30 AM ET
Company Participants
Naomi Aoki - IR
Nancy Simonian - CEO
Joe Ferra - CFO
David Roth - CMO
Conference Call Participants
Phil Nadeau - Cowen and Company
Ted Tenthoff - Piper Sandler
Jason Butler - JMP Securities
Mark Breidenbach - Oppenheimer
Zegbeh Jallah - ROTH Capital Partners
Presentation
Operator
Good morning, and welcome to Syros Pharmaceuticals' Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors and Media section of Syros' website